Chairs
Current Chair: Neha Patel
Chair-elect candidate: Dania Alhamad
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
FDA notice on sitagliptin contamination
November 9, 2022
FDA notice on sitagliptin contamination The Food and Drug Administration…
New Meds and Tech: Qsymia®
September 6, 2022
New Meds and Tech from PES Drugs and Therapeutics committee…
New Meds and Tech: FreeStyle Libre 3™
September 6, 2022
New Meds and Tech from PES Drugs and Therapeutics committee…